台股 » 個股 » 智基 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

智基

(6294)
可現股當沖
  • 股價
    103.0
  • 漲跌
    ▲0.5
  • 漲幅
    +0.49%
  • 成交量
    42
  • 產業
    上櫃 文化創意指數
  • 106人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
智基 (6294)籌碼相關-中國信託-中壢 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

中國信託-中壢 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/05/162106.5000.00107.0021501.33%
2024/05/142100.451102.00102.0011440.69%
2024/05/131107.0011107.00107.00-10127-7.86%
2024/04/2911118.2700.00117.50111169.44%
2024/04/1000.001127.00127.00-195-1.04%
2024/04/0200.000.7123.50123.50-0.770-0.99%
2024/03/261123.0000.00123.001631.57%
2024/03/2200.0027123.69122.50-2760-44.83%
2024/03/2100.0032122.23121.50-3258-54.65%
2023/12/292115.0000.00115.002248.02%
2023/07/2800.001114.50115.00-132-3.09%
2023/07/261111.0000.00111.001313.19%
2023/07/2500.001110.50110.50-131-3.23%
2023/07/141108.0000.00108.501303.31%
2023/07/0700.001107.50107.50-141-2.41%
2023/04/2400.001108.50109.00-153-1.88%
2023/04/131118.5028118.50119.50-2747-56.39%
2023/04/0600.008119.00120.00-837-21.54%
2023/03/2700.003118.50117.50-333-8.88%
2023/03/1400.001112.00112.00-132-3.08%
2022/12/0800.001103.00105.00-138-2.60%
2022/12/072101.2500.00100.502365.45%
2022/09/0800.002108.50109.50-216-11.81%
2022/05/131102.0000.00102.501402.50%
2022/05/1200.003109.00109.00-333-8.94%
2022/04/111134.0000.00134.501224.37%
2021/12/1400.001124.00123.00-132-3.05%
2021/12/1300.001125.50125.50-132-3.05%
2021/11/1900.000.1128.50128.50-0.130-0.17%
2021/10/131126.0000.00125.001402.47%
2021/06/081148.0000.00147.001442.23%
2020/11/024111.5000.00112.0043112.74%
2020/10/306112.5000.00111.5063118.97%
2020/09/1100.001111.50111.50-151-1.93%
2020/08/201107.5000.00107.501561.76%
2020/08/1913108.5000.00108.50135722.68%
2020/08/0516105.5000.00106.00166126.05%
2020/07/3110105.2500.00106.00106315.74%
2020/07/284105.0000.00104.004636.28%
2020/07/155107.4000.00107.005637.85%
2020/07/1410107.0000.00107.00106315.76%
2020/07/135107.0000.00107.005637.88%
2020/05/084102.5000.00102.504429.31%
2020/04/23899.9400.00100.0084417.86%
2020/04/22399.4300.0099.603446.75%
2020/03/3100.00196.0096.00-142-2.37%
2020/03/254796.4900.0095.704740115.34%
2020/03/2400.00194.5094.00-139-2.56%
2020/03/23285.5000.0090.502395.06%
2020/03/1900.00182.5082.10-137-2.65%
2019/10/1700.000.1102.00101.50-0.124-0.20%
2019/08/3000.000.1103.00101.50-0.141-0.12%
2018/12/2800.003103.00104.00-327-10.79%
2018/11/2800.001104.00105.00-128-3.53%
2018/04/131124.5000.00125.5011630.61%
2018/03/2700.001128.50129.00-1163-0.61%
2018/02/261119.0000.00116.5011720.58%
2018/01/1700.001121.50121.50-1129-0.77%
2018/01/1500.001117.00118.00-1114-0.87%
慧智基因前列腺癌基因檢測套組 推行至國內千名患者Anue鉅亨-2021/09/14
疫情推升醫材需求強 雃博5月營收創同期高 慧智基因寫新猷Anue鉅亨-2021/06/10
智基 相關文章
智基 相關影音